首页|期刊导航|中西医结合肝病杂志|清木丹颗粒联合富马酸丙酚替诺福韦治疗慢性乙型肝炎湿热内蕴证的临床疗效观察

清木丹颗粒联合富马酸丙酚替诺福韦治疗慢性乙型肝炎湿热内蕴证的临床疗效观察OA

The efficacy of Qingmu Dan granules combined with tenofovir alafenamide fumarate on the chronic hepatitis B patients with syndrome of accumulated dampness-heat

中文摘要英文摘要

目的:探讨清木丹颗粒联合富马酸丙酚替诺福韦(TAF)治疗慢性乙型肝炎(CHB)湿热内蕴证患者的临床疗效及对肝纤维化的影响.方法:选取2022年9月至2024年9月收治的84例CHB湿热内蕴证患者,采用随机数字表法分为观察组和对照组,每组42例.对照组接受TAF抗病毒及保肝治疗,观察组在对照组基础上联合清木丹颗粒口服,疗程24周.两组各脱落2例,最终每组完成40例.比较两组临床疗效、中医症状评分、肝功能、肝纤维化指标、血清炎症指标以及不良反应.结果:治疗后,观察组总有效率高于对照组,中医证候积分显著低于对照组(P<0.05).重复测量方差分析结果显示,两组丙氨酸氨基转移酶(ALT)、肝脏硬度值(LSM)、层黏连蛋白(LN)、Ⅲ型前胶原(PCⅢ)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)表达水平均存在显著的时间效应与组间交互效应(均P<0.05);天门冬氨酸氨基转移酶(AST)、透明质酸(HA)和Ⅳ型胶原(Ⅳ-C)的时间效应显著(均P<0.05);转化生长因子-β1(TGF-β1)存在时间与组间效应(P<0.05).治疗12周和24周后,观察组患者ALT、AST、LSM、LN、PCⅢ、Ⅳ-C、TNF-α、TGF-β1、IL-6表达水平均低于对照组(P<0.05);24周时观察组患者HA亦低于对照组(P<0.05).两组患者不良反应率比较差异无统计学意义(12.50%vs 7.50%,P>0.05).结论:清木丹颗粒联合TAF可显著提高CHB湿热内蕴证患者临床疗效,改善中医证候、肝功能及肝纤维化指标,减轻炎症反应,且安全性良好.

Objective:Based on the"host-guest interaction"theory,exploring the therapeutic effect of Qingmu Dan Granules combined with tenofovir alafenamide fumarate(TAF)on the chronic hepatitis B(CHB)patients with the syndrome of accumulated dampness-heatand its effect on liver fibrosis.Methods:84 CHB patients with the syndrome of accumulated dampness-heat admitted to our hospital from September 2022 to September 2024 were randomly divided into an observation group and a control group,with 42 patients in each group,using a random number table method.The control group received TAF antiviral therapy for 24 weeks,while the observation group received the same treatment as the control group and additionally received Qingmu Dan granules in combination for 24 weeks.During the research process,2 patients fell out of each group,and a total of 80 patients completed the study,with 40 patients in each group.Compare the overall effectiveness of treatment,traditional Chinese medicine(TCM)syndrome scores,liver function,liver fibrosis indicators,serum inflammation indicators,and incidence of adverse reactions between two groups of patients.Results:The total effective rate of the observation group was higher than that of the control group,and the TCM syndrome score after treatment of the observation group was significantly lower than that of the control group(P<0.05).The results of repeated measures ANOVA showed that there were significant time effects and inter group interaction effects(P<0.05)in alanine aminotransferase(ALT),liver stiffness measurement(LSM)value,laminin(LN),typeⅢprocollagen(PCⅢ),tumor necrosis factor-α(TNF-α),and interleukin(IL-6)in both groups.The time effects of aspartate aminotransferase(AST),hyaluronic acid(HA),and type Ⅳ collagen(Ⅳ-C)were significant(all P<0.05).The existence time and inter group effects of transforming growth factor-β 1(TGF-β1)were both statistically significant(P<0.05).After 12 or 24 weeks of treatment,the levels of ALT,AST,LSM,LN,PC Ⅲ,Ⅳ-C,TNF-α,TGF-β1,and IL-6 in the observation group were significantly lower than those in the control group(all P<0.05).After 24 weeks of treatment,the HA level in the observation group were significantly reduced compared to that in the control group(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(12.50%vs 7.50%,P>0.05).Conclusion:The combination of Qingmu Dan granules and TAF significantly improved the overall treatment efficacy,TCM syndrome scores,liver function and fibrosis parameters,and inhibiting inflammatory reactions in the CHB patients with the syndrome of accumulated dampness-heat,with a favorable safety profile.

宋春荣;南然;刘永刚;黄玉;席奇;常占杰

陕西中医药大学附属医院肝病医院(陕西 咸阳,712000)陕西中医药大学附属医院肝病医院(陕西 咸阳,712000)陕西中医药大学附属医院肝病医院(陕西 咸阳,712000)陕西中医药大学附属医院肝病医院(陕西 咸阳,712000)陕西中医药大学附属医院肝病医院(陕西 咸阳,712000)陕西中医药大学附属医院肝病医院(陕西 咸阳,712000)

医药卫生

清木丹颗粒富马酸丙酚替诺福韦慢性乙型肝炎湿热内蕴证"主客交"理论

Qingmu Dan granulestenofovir alafenamide fumaratechronic hepatitics Bsyndrome of accumulated dampness-heat"host-guest interaction"theory

《中西医结合肝病杂志》 2026 (8)

982-986,5

全国名老中医药专家常占杰传承工作室建设项目(国中医药人教函[2022]75号)

10.3969/j.issn.1005-0264.2026.008.008

评论